SOPHARMA AD - Initiation of negotiations for potential acquisition of Pharmanova, Republic of Serbia

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. SFA_Pharmanova_14072023_espi_88.pdf Initiation of negotiations for potential acquisition of Pharmanova, Republic of Serbia
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 88 / 2023

Date of issue: 2023-07-14

Short name of the issuer

SOPHARMA AD

Subject

Initiation of negotiations for potential acquisition of Pharmanova, Republic of Serbia

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

“Sopharma” AD (the Company) ) notifies that in implementation of a decision of the Board of Directors after a detailed analysis and negotiations, "Sopharma" AD signed a contract for the phased acquisition of the Serbian pharmaceutical manufacturer Pharmanova within two years. The deal is subject to approval by the Serbian Competition Commission and will start with the acquisition of 25% of the Company, followed by the acquisition of 50% after one year and 25% after two years, respectively.

Pharmanova sells its products with leading consumer brands in the markets of Serbia, Bosnia, Montenegro and Macedonia. For 2022, the company's net sales revenues amount to ТEUR 10 225.

Annexes

File Description

SFA_Pharmanova_14072023_espi_88.pdfSFA_Pharmanova_14072023_espi_88.pdf Initiation of negotiations for potential acquisition of Pharmanova, Republic of Serbia

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-07-14 Ognian Donev Executive director